Alpha Cognition (ACOG) Other Accumulated Expenses (2023 - 2025)
Alpha Cognition's (ACOG) quarterly Other Accumulated Expenses came in at $1.6 million in Q4 2025, up 72.5% year-on-year from $923550.0 in Q4 2024, and up 15.93% quarter-over-quarter from $1.4 million in Q3 2025.
Alpha Cognition (ACOG) Other Accumulated Expenses (2023 - 2025) Analysis & Trends
Alpha Cognition's Other Accumulated Expenses history runs 3 years deep, the most recent figure standing at $1.6 million for Q4 2025.
- On a quarterly basis, Other Accumulated Expenses rose 72.5% year-over-year to $1.6 million in Q4 2025; TTM through Dec 2025 was $1.6 million, a 72.5% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 72.5% from the prior year.
- Other Accumulated Expenses grew to $1.6 million in Q4 2025 per ACOG's latest filing, from $1.4 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $1.6 million in Q4 2025 and bottomed at $127284.0 in Q4 2023.
- The 3-year median for Other Accumulated Expenses is $864655.5 (2024), against an average of $830558.6.
- Across the five-year window, Other Accumulated Expenses jumped 625.58% in 2024 and soared 72.5% in 2025, its largest moves.
- Year by year, Other Accumulated Expenses stood at $127284.0 in 2023, then soared by 625.58% to $923550.0 in 2024, then jumped by 72.5% to $1.6 million in 2025.
- Per Business Quant, the three latest ACOG Other Accumulated Expenses figures stand at $1.6 million (Q4 2025), $1.4 million (Q3 2025), and $805761.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.04 Bn | 467.25 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.28 Bn | 115.03 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 56.16 Bn | 50.98 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn |
| 10 | Alpha Cognition | 149.05 Mn | 82.94 Mn | 2.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.59 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 805,761.00 |
| Mar 31, 2025 | 1.27 Mn |
| Dec 31, 2024 | 923,550.00 |
| Sep 30, 2024 | 274,955.00 |
| Jun 30, 2024 | 275,574.00 |
| Dec 31, 2023 | 127,284.00 |